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Abstract
The functional role of ELR-positive CXC chemokines in host defense during acute viral-induced encephalomyelitis was
determined. Inoculation of the neurotropic JHM strain of mouse hepatitis virus (JHMV) into the central nervous system (CNS)
of mice resulted in the rapid mobilization of PMNs expressing the chemokine receptor CXCR2 into the blood. Migration of
PMNs to the CNS coincided with increased expression of transcripts specific for the CXCR2 ELR-positive chemokine ligands
CXCL1, CXCL2, and CXCL5 within the brain. Treatment of JHMV-infected mice with anti-CXCR2 blocking antibody reduced
PMN trafficking into the CNS by .95%, dampened MMP-9 activity, and abrogated blood-brain-barrier (BBB) breakdown.
Correspondingly, CXCR2 neutralization resulted in diminished infiltration of virus-specific T cells, an inability to control viral
replication within the brain, and 100% mortality. Blocking CXCR2 signaling did not impair the generation of virus-specific T
cells, indicating that CXCR2 is not required to tailor anti-JHMV T cell responses. Evaluation of mice in which CXCR2 is
genetically silenced (CXCR22/2 mice) confirmed that PMNs neither expressed CXCR2 nor migrated in response to ligands
CXCL1, CXCL2, or CXCL5 in an in vitro chemotaxis assay. Moreover, JHMV infection of CXCR22/2 mice resulted in an
approximate 60% reduction of PMN migration into the CNS, yet these mice survived infection and controlled viral
replication within the brain. Treatment of JHMV-infected CXCR22/2 mice with anti-CXCR2 antibody did not modulate PMN
migration nor alter viral clearance or mortality, indicating the existence of compensatory mechanisms that facilitate
sufficient migration of PMNs into the CNS in the absence of CXCR2. Collectively, these findings highlight a previously
unappreciated role for ELR-positive chemokines in enhancing host defense during acute viral infections of the CNS.
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Introduction
Inoculation of the neurotropic JHMV strain of mouse hepatitis
virus (a positive-strand RNA virus and member of the Coronaviridae
family) into the CNS of susceptible strains of mice results in an
acute encephalomyelitis, characterized by wide spread infection
and replication within astrocytes, microglia, and oligodendrocytes,
while relatively sparing neurons [1]. Mechanisms associated with
control of viral growth are dictated by the infected host cell.
Astrocytes and microglia are susceptible to perforin-mediated lysis
by cytotoxic T lymphocytes [2], whereas IFN-c suppresses viral
replication within oligodendrocytes [3]. Although a robust cell-
mediated immune response occurs during acute disease, sterilizing
immunity is not achieved, resulting in viral persistence [4]. While
virus-specific CD8
+ T cells are retained within the CNS of
persistently infected mice and lytic activity is muted, these cells
retain the capacity to secrete IFN-c that limits viral replication
in oligodendrocytes [3,5–7]. Histological features associated
with viral persistence include the development of an immune-
mediated demyelinating disease similar to the human demye-
linating disease multiple sclerosis (MS), with both T cells and
macrophages being important in amplifying disease severity by
contributing to myelin damage [8,9].
Chemokines are rapidly secreted within the CNS in response to
JHMV infection and contribute to host defense [10–14] and disease
progression [10,15–17]. The ELR+ (glutamic acid – leucine –
arginine) CXC chemokines CXCL1 and CXCL2 are up-regulated
within the brains of JHMV-infected mice [11,18,19], yet little is
known regarding their biological significance or cellular targets.
CXCL1 and CXCL2 are potent chemoattractants for PMNs,
binding and signaling through their receptor CXCR2 [20–22].
Moreover, PMNs have been shown to enhance CNS inflammation
by disrupting blood brain barrier (BBB) integrity in animal models of
spinal cord injury (SCI) [23,24], autoimmune demyelination [25],
and JHMV-induced encephalomyelitis [26]. In addition, blocking or
silencing of CXCR2 signaling mutes inflammation and tissue damage
in mouse models in which PMN infiltration is critical to disease
initiation, including SCI [23], inflammatory demyelination [25],
bacterial infection of the CNS [27], and viral infection or injury to the
lung [28–32]. With regards to JHMV infection, depletion of PMNs
increases mortality due to abrogated BBB permeabilization and
subsequent diminished T cell infiltration into the CNS, however the
relationship between CXCR2 signaling and PMN migration during
viral infection of the CNS has yet to be determined.
The present study was undertaken to characterize the functional
role of ELR+ chemokines in either host defense or disease
PLoS Pathogens | www.plospathogens.org 1 November 2009 | Volume 5 | Issue 11 | e1000648following viral infection of the CNS. Using JHMV infection as a
model of viral-induced encephalomyelitis, we demonstrate a
protective role for ELR-positive chemokines in promoting PMN
migration to the CNS and subsequent BBB degradation, facilitating
the entry of T lymphocytes and control of viral replication.
Results
CXCR2-positive PMNs are rapidly recruited to the CNS in
response to JHMV infection
To evaluate the early immune response following JHMV
infection, C57BL/6 mice were intracerebrally (i.c.) inoculated with
JHMV, and the accumulation of neutrophils within the blood and
the CNS was monitored. Within the brain, JHMV titers peaked at
day 3 p.i. and gradually declined to below the level of detection
(,100 PFU/g) by day 15 p.i. (Figure 1A). Elevated numbers of
neutrophils were observed within the blood as early as day 1 p.i.
PMN peaked at day 3 p.i, before rapidly returning to sham levels
by day 7 p.i. (Figure 1C). Similarly, neutrophil infiltration into
the CNS peaked at day 3 p.i. and subsequently returned to
baseline levels by day 7 p.i. (Figure 1E). The chemokine receptor
CXCR2 was expressed on the majority of PMNs within the blood
(Figure 1D) and brain (Figure 1F), as assessed by flow
cytometry. The pattern of neutrophil infiltration into the CNS
was unique, as the infiltration of inflammatory leukocytes
(CD45
high) and macrophages (F4/80
+CD45
high) steadily increased
to day 7 p.i. (Figure 1B). As the majority of neutrophils were
CXCR2-positive, we next determined the expression pattern of
chemokine ligands capable of binding and signaling through
CXCR2 within the brain during JHMV infection. Expression of
transcripts for the ELR-positive chemokines CXCL1, CXCL2,
and CXCL5, as well as CXCR2, paralleled PMN recruitment into
CNS, peaking at day 3 p.i. and returning to baseline levels by day
12 p.i. (Figure 2A). Immunostaining for CXCL1 and the
astrocyte marker GFAP at day 3 p.i. revealed dual-positive cells
located within the parenchyma and associated with the microvas-
culature (Figure 2B). Staining was concentrated within the
hippocampal region of the brain. The majority (.80%) of
CXCL1-positive cells were astrocytes, as defined by GFAP
staining, although endothelial cells also appeared positive, given
the enriched CXCL1 signal intensity surrounding the vessel wall
(Figure 2B). These results are consistent with previous results
[11,33–35] that astrocytes, as well as endothelial cells, are capable
of producing this CXCR2 ligand. These data indicate that JHMV
infection and replication results in regulated expression of ELR+
chemokines and CXCR2 within the CNS that parallels neutrophil
mobilization into the blood and migration into the CNS.
CXCR2 neutralization prevents neutrophil accumulation
within the CNS during acute JHMV-induced disease
To assess the role of CXCR2 during acute viral encephalomy-
elitis, JHMV infected C57BL/6 mice were treated with neutral-
izing polyclonal CXCR2 antiserum or control rabbit serum
(NRS), and the effect on PMN accumulation within the CNS
determined. As shown in Figure 3A, representative FACS dot
plots revealed an almost complete absence of PMN accumulation
at day 3 p.i. within the CNS of mice treated with anti-CXCR2
blocking antibody. Enumeration of total PMN infiltration to the
brain showed a significant reduction compared to mice treated
with control serum at days 1 (p,0.05) and 3 p.i. (p,0.01)
(Figure 3A). CXCR2 neutralization also retarded the
accumulation of total inflammatory cells (Figure 3B) and
macrophages (Figure 3C) at day 3 p.i. Further, treatment with
CXCR2 antiserum resulted in a significant (p,0.05) reduction of
neutrophil numbers within the blood at day 3 p.i. (Figure S1).
Importantly, anti-CXCR2 treatment did not induce complement-
mediated lysis or neutrophil depletion from bone-marrow (data
not shown). Previously, neutrophils have been deemed partly
responsible for the permeabilization of the BBB following JHMV
infection [19,26], therefore, we assessed BBB integrity in the
brains of mice treated with either anti-CXCR2 or NRS. Indeed,
compared to NRS treatment, CXCR2 neutralization significantly
(p,0.05) reduced BBB breakdown, as measured by Evans Blue
uptake (Figure 3D). However, BBB permeability in anti-CXCR2
treated mice was not completely eliminated compared to sham –
infected mice (Figure 3D). Previous studies indicated that MMP-
9 expression by PMN is associated with BBB permeabilization in
response to JHMV infection [19,26]. Consistent with reduced
numbers of neutrophils in the brains of anti-CXCR2 treated mice,
MMP-9 activity was significantly (p,0.001) muted within the
brains, whereas detectable levels of enzyme activity were
observable within the brains of NRS treated mice (Figure 3E
&3 F ). These data indicate that CXCR2 signaling promotes the
directed migration of neutrophils from the periphery to the CNS,
thus facilitating the degradation of the BBB in response to JHMV
infection.
CXCR2 neutralization exacerbates mortality, delays viral
clearance, and dampens neuro – inflammation
To better assess the functional role of CXCR2 in host defense,
JHMV-infected mice were treated with anti-CXCR2 beginning
day 21 p.i. and continuing throughout acute disease. Mice began
to die at day 4 p.i. and 100% of mice treated with anti-CXCR2
were dead by day 11 p.i., while greater than 90% of infected mice
treated with control serum survived until day 12 p.i. (Figure 4A).
Anti-CXCR2-treated mice were also unable to control viral
replication within the brain, as evidenced by the significantly
elevated viral titers at days 7 (p,0.05) and 9 p.i. (p,0.01),
compared to mice treated with control serum (Figure 4B). Sham
Author Summary
Consequences of viral infection of the central nervous
system (CNS) can range from encephalitis and paralytic
poliomyelitis to relatively benign infections with limited
clinical outcomes. The localized expression of proinflam-
matory chemokines within the CNS in response to viral
infection has been shown to be important in host defense
by attracting antigen-specific lymphocytes from the
microvasculature into the parenchyma that control and
eventually eliminate the replicating pathogen. However,
the relationship between chemokine expression and
recruitment of myeloid cells, e.g. neutrophils, to the CNS
following infection with a neurotropic virus is not well
characterized. Emerging evidence has indicated that the
mobilization of neutrophils into the blood and recruitment
to the CNS following microbial infection or injury
contributes to permeabilization of the blood-brain-barrier
that subsequently allows entry of inflammatory leukocytes.
Therefore, we have defined the chemokines involved in
promoting the directional migration of neutrophils to the
CNS in response to viral infection. Using the neurotropic
JHM strain of mouse hepatitis virus (JHMV) as a model of
acute viral encephalomyelitis, we demonstrate a previously
unappreciated role for members of the ELR-positive CXC
chemokine family in host defense by attracting PMNs
bearing the receptor CXCR2 to the CNS in response to viral
infection.
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of morbidity or mortality (data not shown). To further explore the
consequences of blocking CXCR2 signaling early following
infection, neuroinflammation was assessed by H&E staining of
brains from JHMV-infected mice treated with either anti-CXCR2
or control sera at day 9 p.i. Such analysis revealed limited
inflammatory cell infiltration, as demonstrated by an overall
reduction in the size of the meningeal and perivascular infiltrates
(Figure 4D), compared to mice treated with control serum
(Figure 4C). Consistent with the reduced inflammation observed
histologically, immunophenotyping the cellular infiltrate in the
brain revealed an overall reduction in CD45
high cells present
within the brains of infected mice treated with anti-CXCR2
(Figure 4E). Moreover, blocking CXCR2 reduced CD8
+
(Figure 4F) and CD4
+ (Figure 4G) T cell infiltration, as well
as reduced the numbers of virus-specific CD4
+ and CD8
+ T cells
(Figure 4H) within the brains compared to control-treated mice.
In contrast, if administration of anti-CXCR2 was delayed until 2
Figure 1. CXCR2+ neutrophils peak early during JHMV infection. C57BL/6 mice were i.c. infected with 500 PFU JMHV; blood and brains were
removed at defined times p.i. for viral titer or flow cytometric analysis. (A) Following infection JHMV rapidly replicates within the brains of infected
mice, peaking at day 3 p.i. Within the (C) blood and (E) brains of infected mice, neutrophils peak at day 3 p.i. before quickly returning to sham levels
by day 7 p.i. Approximately 80% of these neutrophils within the (D) blood and (F) brain are CXCR2-positive. The infiltration kinetics of neutrophils are
unique to this subset of cells, as (B) both total inflammatory cells (CD45
high) and macrophages (CD45
highF4/80
+) continue to infiltrate or maintain
their levels from day 3 until day 7 p.i. Data are representative of 2 independent experiments with a minimum of 3 mice per time point.
doi:10.1371/journal.ppat.1000648.g001
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unaffected, when compared to control-treated mice (Figure S2A–
D). Notably, a single treatment of CXCR2 antiserum at day +2
p.i. significantly (p,0.01) reduced neutrophil infiltration into the
CNS at day 3 p.i. (anti-CXCR2, 8.3610
361.7610
3 cells/g, n=5)
compared to control-treated mice (5.0610
561.2610
5,n = 5 )
(Figure S2E). However, compared to mice that were treated
with CXCR2 antiserum beginning at day 21 p.i., the levels of
neutrophils within the CNS at day 3 p.i. was approximately 5
times greater [anti-CXCR2, 1.7610
362.7610
2, n=5; control-
treated, 3610
561.8610
4,n = 3 )( Figure 3A). These findings
indicate that CXCR2 signaling is protective; however the period
of protection is confined to the earliest days following JHMV
infection, coinciding with dramatic mobilization of PMNs from
the blood and subsequent migration into the CNS.
Blocking CXCR2 does not affect generation of virus-
specific T cells
We next determined if CXCR2 signaling was important in the
generation of virus-specific T cells. C57BL/6 mice were treated
with either anti-CXCR2 or control serum beginning at day 21
prior to being infected i.c. with JHMV, and the presence of virus-
specific T cells within the draining cervical lymph nodes (CLN)
[36] was determined at day 7 p.i. by evaluating ex vivo responses to
defined CD4+ and CD8+ T cell-specific viral epitopes [37–39].
Similar numbers of virus – specific CD8+ T cells were generated in
mice treated with either anti-CXCR2 or control sera as
determined by measuring S510–518 MHC class I tetramer –
reactive cells (Figure 5A) and intracellular staining for IFN-c
within cultured cells pulsed with either the S510–518 (Figure 5B)o r
S598–605 (Figure 5C) peptides. Similarly, there were no differences
in the numbers of CD4+ T cells recognizing the M133–147 peptide
in anti-CXCR2-treated mice compared to control mice
(Figure 5D). It has been reported that the absence of CXCR2
abrogates peripheral immune responses to pathogens [40–46],
therefore we also sought to determine whether antiviral responses
were muted following CXCR2 neutralization following intraper-
itoneal (i.p.) challenge with JHMV. C57BL/6 mice were treated
with either anti-CXCR2 or control serum beginning at day -1
before being infected i.p. with virus. The presence of virus –
specific T cells within the spleen was assessed as described above.
Similar frequencies and numbers of virus – specific CD8+ and
CD4+ T cells were generated in both control and anti-CXCR2
antiserum treated animals (Figure 6 A–D). Moreover, no
difference in the expression of the T cell activation markers
CD25, CD127, and CD44 was observed upon splenic T cells from
mice treated with CXCR2 antiserum (Figure 6E and F). Finally,
i.p. infection of CXCR22/2 mice with JHMV did not affect the
generation of virus-specific CD4+ or CD8+ T cells compared to
infected CXCR2+/+ mice (Figure S3). Therefore, these data
clearly indicate that CXCR2 signaling does not influence the
generation or expansion of virus – specific T cells following JHMV
infection.
CXCR2 deficiency attenuates neutrophil infiltration to the
CNS without affecting survival or viral clearance
following JHMV infection
We next utilized mice in which CXCR2 signaling was
genetically silenced (CXCR22/2 mice) to further assess the
functional role of CXCR2 in host defense in response to JHMV
infection of the CNS. First, we sought to ensure that CXCR2 –
deficient neutrophils were unresponsive to defined CXCR2
chemokine ligands. Our findings confirmed that PMNs isolated
from the bone-marrow of CXCR22/2 mice did not express
CXCR2 (Figure 7A), and, unlike CXCR2+/+ PMN, CXCR22/2
PMN did not migrate in vitro in response to recombinant mouse
CXCL1, CXCL2, or CXCL5 (Figures 7 B–D), consistent with
previous reports [47,48]. CXCR22/2 mice inoculated i.c. with
JHMV exhibited an approximate 60% reduction (p,0.05) in
PMN migration to the CNS compared to wildtype littermates at
day 3 p.i. (Figure 8A). However, neutrophil infiltration into the
CNS of CXCR22/2 mice was not completely eliminated, as
previously observed following anti-CXCR2 treatment of JHMV-
infected wildtype mice (Figure 3A). Correspondingly, there was
no difference in mortality (Figure 8B) or brain viral titers
(Figure 8C) between JHMV-infected CXCR22/2 mice and
CXCR2+/+ mice. Additionally, both CXCR22/2 and CXCR2+/+
displayed similar amounts of Evans Blue extravasation into the
Figure 2. CXCR2 and ELR
+ chemokines are expressed in the brain during acute JHMV infection. C57BL/6 mice were i.c. infected with
500 PFU JMHV and brains removed at defined times p.i. to determine the expression of transcripts specific for CXCR2, CXCL1,-2, and -5 using semi-
quantitative PCR analysis (A). Data represent the fold-induction compared to sham-infected mice (n=3–5 per time point, *p,0.05, **p,0.01,
***p,0.001). (B) Representative immunofluorescence staining of brain at day 3 p.i. for astrocytes (GFAP, red staining indicated by arrowheads) and
CXCL1 (green staining, indicated by asterisks). Dual-positive cells (indicated by arrows within the merged image) were present surrounding the vessel
wall as well as within the parenchyma. CXCL1 staining was enriched within the hippocampus at day 3 p.i. Bar =10 mm.
doi:10.1371/journal.ppat.1000648.g002
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mechanisms that may allow for CXCR22/2 neutrophils to enter
the CNS, we evaluated expression of CXCR1, an alternate
receptor for ELR+ chemokines [49], on neutrophils. Neutrophils
isolated from the bone marrows of CXCR22/2 mice exhibited
enriched levels of CXCR1 mRNA transcripts compared to
Figure 3. CXCR2 neutralization prevents CNS PMN infiltration and abrogates BBB breakdown. C57BL/6 mice i.c. infected with 500 PFU
JMHV were pretreated with CXCR2 neutralizing antiserum or control NRS every other day beginning at day -1 p.i. Brains were removed at days 1 and 3
p.i. to assess cellular infiltration, Evans Blue (EB) extravasation, or MMP activity. CXCR2 neutralization significantly reduced (A) the frequency and total
numbers of neutrophils within the brain at day 1 and 3 p.i. The infiltration of (B)C D 4 5
high-expressing cells and (C) macrophages was also significantly
reduced at day 3 p.i. Concomitant with the absence of PMN accumulation, CNS EB extravasation (D) was significantly reduced compared to NRS-treated
mice, although BBB permeability was greater than sham mice. Additionally, MMP9 activity was undetectable in anti-CXCR2 treated brains compared to
NRS-treated mice (F). Quantificationof MMP9 activity revealed a significant increase in MMP9 activity compared to both sham andinfectedmice treated
with CXCR2 antiserum (E). Data in panels A–F represents 2 independent experiments with a minimum of 3 mice per time point for each experimental
group. For panel F, each lane represents an individual mouse. *p,0.05, **p,0.01, ***p,0.001 compared to NRS-treated mice.
doi:10.1371/journal.ppat.1000648.g003
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PLoS Pathogens | www.plospathogens.org 5 November 2009 | Volume 5 | Issue 11 | e1000648Figure 4. Neutralizing CXCR2 during acute JMHV infection increases mortality, viral burden, and reduces T lymphocyte infiltration.
CXCR2neutralizingantiserumor normalrabbit serum(NRS)wasadministeredevery otherdayfromdays-1to11p.i.toC57BL/6micei.c.infected with500P F Uo f
JMHV. The shaded area indicates the treatment window. Treatment with anti-CXCR2 significantly increased mortality (A) compared to NRS-treated mice (anti-
CXCR2, n=10; NRS, n=10), and this was associated with increased viral titers within the brains (B) of anti-CXCR2-treated mice compared to control mice. Data
presentedwithinpanelsAandBarecumulativeresultsfrom2experiments.RepresentativeH&Estainingofbrainsfrom(C)NRSor(D)anti-CXCR2miceatday9p.i.
reveals a drastic reduction in meningeal (arrows) and parenchymal (arrowhead) inflammation following CXCR2 neutralization. Flow cytometric analysis revealed
significantly reduced cellular infiltration of CD45
high cells (E)a n db o t hC D 8 b
+ (F)a n dC D 4
+ (G) T lymphocyte subsets. In addition, intracellular IFN-c staining
following ex vivo stimulation with immunodominant CD4+ (M133–147)o rC D 8 + (S510–518) epitopes revealed reduced numbers of virus-specific T cells within the
brains of anti-CXCR2-treated mice compared to NRS-treated mice at day 7 p.i. (H). Data in panels E-H are representative of 2–4 independent experiments with a
minimum of 4 mice per time point in each experimental group. *p,0.05, **p,0.01, ***p,0.001 compared to NRS-treated mice. Bars: (C&D )1 0 0mm.
doi:10.1371/journal.ppat.1000648.g004
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an alternate receptor for migration to the CNS (Figure 8E). In
order to demonstrate that the CXCR2 anti-serum did not have
any off – target effects, JHMV – infected CXCR2 – deficient and
wildtype littermates were treated with anti-CXCR2 or NRS
beginning at day -1 p.i. and PMN migration into the CNS at day 3
p.i. was determined. As shown in Figure S4A, anti-CXCR2
treatment did not affect neutrophil accumulation into the brains of
CXCR22/2 animals, compared to CXCR22/2 mice receiving
control serum. Similar numbers and frequencies of PMNs were
also present within the CNS of knockout mice treated with either
anti-CXCR2 antiserum or control serum (Figure S4A) compared
to untreated CXCR22/2 mice infected with JHMV (Figure 8A).
In contrast, anti-CXCR2 treatment of JHMV-infected CXCR2+/+
mice reduced (.96%) PMN migration to the CNS (Figure S4B).
These findings indicate that the CXCR2 blocking antibody is
specific and suggest that genetic deletion of CXCR2 allows for
compensatory mechanisms to emerge, such as utilization of
CXCR1, that support PMN trafficking into the CNS in response
to viral infection.
Discussion
We have examined the role of ELR+ chemokines in host
defense following infection of susceptible mice with the neuro-
tropic coronavirus, JHMV. Early following JHMV infection,
CXCR2-positive neutrophils are mobilized into the bloodstream
and migrate to the CNS in response to elevated expression of the
ELR+ chemokines CXCL1, CXCL2, and CXCL5. Early
administration of a blocking antibody specific for CXCR2 to
JHMV-infected mice reduced .95% of PMN migration into the
CNS, and this corresponded with increased mortality and
uncontrolled viral replication. Subsequent studies revealed that
anti-CXCR2 treatment prevented PMN-mediated BBB permea-
bilization, associated with muted MMP-9 activity, and ultimately
resulted in the impaired accumulation of virus-specific T cells
within the CNS. These findings emphasize the importance of
rapid neutrophil recruitment to the CNS in response to viral
infection of the CNS to facilitate control of viral replication.
Moreover, our findings highlight that the numbers of neutrophils
recruited to the CNS is critical in defense as JHMV-infection of
CXCR22/2 mice or delayed anti-CXCR2 treatment resulted in
efficient control of viral replication, and this was associated with
greater numbers of neutrophils within the CNS compared to mice
treated prior to infection with blocking antibody. Collectively, our
studies support and extend others highlighting the functional role
of neutrophils in promoting vascular permeability in response to
infection or injury to the CNS [25,26,50]. This is elegantly
illustrated in the studies by McGavern and colleagues [50] that
defined the importance of myelomonocytic cell recruitment to the
CNS in response to LCMV infection with regards to contributing
to fatal viral meningitis via promoting massive vascular injury.
Importantly, interventional therapies targeting myeloid cell
trafficking to the CNS during acute viral infection may offer a
Figure 5. CXCR2 neutralization does not alter the generation of JHMV – specific T cells. CXCR2 neutralizing antiserum or normal rabbit
serum (NRS) was administered every other day from days 21 to 5 p.i. to C57BL/6 mice i.c. infected with 500 PFU of JMHV. Cervical lymph nodes were
removed on day 7 p.i. Isolated cells were stained with S510–518 MHC-I tetramer (A) or stimulated ex vivo for 6 hours with 5 mM of the
immunodominant CD8 epitope S510–518 (B), or the subdominant CD8 epitope S598–605 (C), or the immunodominant CD4 epitope M133–147 (D), and
stained for IFN-c production. Data is representative of two independent experiments with a minimum of 4 mice per experimental group.
doi:10.1371/journal.ppat.1000648.g005
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PLoS Pathogens | www.plospathogens.org 7 November 2009 | Volume 5 | Issue 11 | e1000648Figure 6. CXCR2 neutralization does not alter the generation of JHMV – specific T cells or total T cell activation within the spleen.
CXCR2 neutralizing antiserum or normal rabbit serum (NRS) was administered every other day from days 21 to 5 p.i. to C57BL/6 mice i.p. infected
with 2.5610
5 PFU of JMHV. Spleens were removed on day 7 p.i. Isolated splenocytes were stained with S510–518 MHC-I tetramer (A) or stimulated ex
vivo for 6 hours with 5 mM of the immunodominant CD8 epitope S510–518 (B), or the subdominant CD8 epitope S598–605 (C), or the immunodominant
CD4 epitope M133–147 (D), and stained for IFN-c production. Gated CD4+ or CD8b+ cells (E) were also assessed for their expression of the T cell
activation markers CD44, CD127, and CD25. CD8b+ cells were negative for CD127 and CD25. The average expression 6 SEM of T cell activation
markers was tabulated in (F, n=3 anti-CXCR2, n=5 NRS). Data in panels A–D is representative of two independent experiments with a minimum of 4
mice per experimental group. Representative FACS plots are shown in panel E.
doi:10.1371/journal.ppat.1000648.g006
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fatalities associated with viral encephalopathies.
In agreement with previous reports [51], we have also observed
that CXCR2 signaling is important for neutrophil release from the
bone marrow into the blood. Blocking CXCR2 dramatically
reduced neutrophil mobilization into the bloodstream in response
to JHMV infection. Notably, neutrophil entry into the blood was
not completely inhibited, indicating that there may be additional
signaling components that aid neutrophil release such as CXCL12
downregulation or G-CSF induction [51,52]. CXCR2 neutraliza-
tion also reduces circulating levels of neutrophils within uninfected
mice (data not shown), suggesting that CXCR2 ligands contribute
to both normal neutrophil homeostasis and emergency release
following infection with a neurotropic virus. Our studies highlight
a previously unappreciated functional role for ELR+ chemokines
in host defense during viral-induced encephalomyelitis, rapidly
recruiting PMNs into the blood with subsequent infiltration into
the CNS, thus enhancing protection by contributing to the
disruption of the BBB and facilitating anti-viral inflammatory T
cell access. The protease MMP-9 is specific for the structural
components of the BBB, including type IV collagen and laminin,
and it is associated with BBB breakdown in a mouse model of
cerebral ischemia [53]. Although MMP-9 is associated with the
loss of BBB integrity following JHMV infection, it is likely that
additional PMN-associated molecules including b2-integrin, azur-
ocidin, and glutamate participate in BBB damage, as these
components can also contribute to the disruption of endothelial
cell adherens junctions [54–58]. Additionally, MMP-9 may also be
contributing to the degradation of the parenchymal basement
membranes and glia limitans that regulate leukocyte infiltration
from the perivascular space into the parenchyma [59].
Infectionof CXCR22/2 micewithJHMVdidnotrecapitulate
our observations with infected wildtype mice treated with
CXCR2 antiserum. While neutrophil infiltration into the CNS
was reduced by approximately 60% at day 3 p.i, CXCR2 –
deficient mice experienced no deficits in survival, viral clearance,
or BBB degradation. Our demonstration that PMN migration to
the CNS of JHMV-infected CXCR22/2 mice was not altered
Figure 7. CXCR2 2/2 neutrophils are unresponsive to CXCR2 ligands. (A) Neutrophils, enriched from the bone marrows of CXCR2+/+ and
CXCR22/2 mice, were stained with CXCR2 antiserum or control rabbit serum (NRS) and processed for flow cytometric analysis. Neutrophils isolated
from CXCR22/2 mice were unreactive for CXCR2 antiserum while approximately 60% of the neutrophils from CXCR2+/+ mice stain positive for
CXCR2. Enriched neutrophils were also stimulated with the recombinant chemokines (B) CXCL1, (C) CXCL2, and (D) CXCL5 at the indicated
concentrations and allowed to migrate for three hours. Data is representative of two independent experiments.
doi:10.1371/journal.ppat.1000648.g007
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the specificity of this reagent and suggests that compensatory
mechanisms allow for sufficient numbers of neutrophils to
migrate to the CNS that enable BBB breakdown and infiltration
of virus-specific T cells. However, it is notable that our
observations are in contrast to previous reports utilizing
CXCR22/2 mice in models of host defense following infection
of the CNS. For example, Del Rio et al. [40] demonstrated
elevated numbers of T. gondii cysts within the brains of CXCR22/
2 mice, yet all of the immune defects occurred within the
periphery, suggesting CXCR2-mediated protection occurs in a
manner independent of leukocyte trafficking. Additionally,
Kielian et al. [27] have shown that in a model of S. aureus
experimental brain abscess neutrophil extravasation into the
brain is impaired in CXCR22/2 mice, resulting in moderately
increased bacterial burdens and pathology. However, the authors
did not assess long-term bacterial clearance in the CXCR2 –
deficient mice, nor quantitate total neutrophil or other immune
cell infiltration that may have been impacted. Moreover, in
experimental brain abscesses, neutrophils have direct anti-
Figure 8. CXCR2 deficiency attenuates neutrophil infiltration but does not affect mortality or viral load. CXCR2+/+ and CXCR22/2 mice
were infected i.c. with 500 pfu JHMV, sacrificed at day 3 or 12 p.i., and brains were processed for FACS and viral titer. (A) Both the frequency and the
total number of neutrophils infiltrating the brains of CXCR22/2 mice were significantly reduced compared to CXCR2+/+ mice. However, no difference
in (B) overall mortality to day 12 p.i., (C) viral load at days 3 and 12 p.i., or (D) EB extravasation into the brains were observed between infected
CXCR2+/+ and CXCR22/2 mice. (E) Qualitative PCR for CXCR1 transcripts revealed comparatively increased CXCR1 mRNA levels within neutrophils
enriched from the bone marrow of CXCR22/2 compared to CXCR2+/+ mice. Data in panels A, C, and D are representative of two independent
experiments, n=3–7 mice/time point. Data in panel B are a summation of two independent experiments, n=9. Each group within panel E represents
mRNA combined from two independent mice. *p,0.01 compared to CXCR2+/+ mice.
doi:10.1371/journal.ppat.1000648.g008
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are responsible for the permeabilization of the BBB [26], so
functional differences of these cells in host defense may explain
differences between the model systems. Our assessment of
CXCR2 staining on neutrophils isolated within both the blood
and brain of wildtype mice revealed that a small population of
neutrophils was unreactive to CXCR2 antiserum. These findings
argue for either transient receptor internalization following
ligand binding [61] or alternative mechanisms of neutrophil
attraction in the absence of CXCR2 signaling. Neutrophils have
been reported to be chemotactic to cleaved complement products
[48], leukotrienes [62], and other chemokines [63–65] in vitro and
in vivo. Moreover, a functional murine homolog for CXCR1 has
recently been identified and this may serve to mediate PMN
trafficking to the CNS in response to JHMV infection [49].
Indeed, neutrophils enriched from the bone marrow of CXCR2
– deficient mice expressed noticeably increased transcripts
specific for CXCR1, whereas transcripts were barely detectable
within neutrophils from wild type mice, indicating that
CXCR22/2 neutrophils may be compensating through in-
creased expression of CXCR1. In addition, we have observed
elevated numbers of PMNs residing within the CNS of
CXCR22/2 mice in the absence of infection (data not shown),
suggesting potentially highly dysregulated myeloid cells in these
mice. The fact that these cells are present prior to JHMV-
infection suggests the possibility that viral infection results in local
activation that contributes to BBB breakdown and may account
for the muted CD11b expression upon CXCR22/2 neutrophils
within the CNS.
Recent evidence indicates that neutrophils are capable of
influencing the generation of an adaptive immune response
following infection. Neutrophil activation results in secretion of
the cytokines IL-12/23 p40 that are associated with tailoring T
cell-specific responses following antigenic challenge [66,67].
Furthermore, neutrophils are capable of secreting chemokines
such as CCL3 and CCL4 that also influence dendritic cell
function, and thus they have been suggested to regulate T cell
polarization via dendritic cell activation [68]. Additionally, the
generation of TH1 immune reponses to a variety of pathogens is
negatively impacted within neutropenic mice [41–46]. However,
our findings clearly indicate that in the absence of CXCR2
signaling there are no deficiencies in either the frequencies or
numbers of JHMV – specific T cells or T cell activation markers,
regardless of whether mice were challenged within the CNS or
peripherally.
Our results complement previous work that has highlighted the
importance of ELR-positive chemokines and PMNs in promoting
vascular permeability and subsequent immune cell infiltration into
the CNS. CNS-specific transgenic expression of CXCL1 was
associated with disruption of the BBB and neutrophil infiltration
into the brain parenchyma [69]. Moreover, blocking CXCR2
signaling inhibits neutrophil-mediated BBB damage and dampens
CNS inflammation in autoimmune demyelination and spinal cord
injury [23–25]. Although the mechanisms associated with
induction of ELR+ chemokines expression within the CNS of
JHMV-infected mice have yet to be characterized, intracerebral
administration or localized transgenic expression of IL-1b within
the brain enhances CXCL1 expression, inducing neutrophil
accumulation and subsequent BBB breakdown [70,71]. Collec-
tively, these findings have implications for other neurotropic
viruses, including West Nile virus, as PMN represent an early and
predominant inflammatory infiltrate in response to viral infection
[72]. Therefore, understanding the signaling mechanisms govern-
ing inflammation in response to viral infection raises the possibility
of selectively muting specific pathways associated with BBB
breakdown and CNS inflammation which may have therapeutic
benefits within the context of human neuroinflammatory diseases
that arise in the apparent absence of an infectious trigger.
Materials and Methods
Virus and mice
Age-matched 5–6 week old C57BL/6 (H-2
b, National Cancer
Institute, Frederick, MD) or 5–9 week old CXCR22/2 (H-2
b,
Cleveland Clinic, OH) mice were infected intracerebrally (i.c.)
with 500 plaque forming units (PFU) of JHMV strain J2.2v-1 in
30 ml of sterile HBSS. Control (sham) animals were injected with
30 ml of sterile saline alone. CXCR2 deficient mice [47] were
originally backcrossed to C57BL/6 mice for 11 generations, and
CXCR22/2 mice used for experimental purposes were obtained
from heterozygous breeder pairs. All pups derived from breeders
were genotyped as previously described [73]. Age and sex –
matched littermate CXCR2+/+ were used as controls for all
experiments with CXCR22/2 mice. To assess the generation of
JHMV – specific T cells, C57BL/6 mice were infected
intraperitoneally (i.p.) with 2.5610
5 PFU of JHMV strain DM.
For analysis of viral titers, one-half of each brain was homogenized
and used for standard plaque assay on the DBT mouse astocytoma
cell line [74] at the indicated days post-infection (p.i.). All
experiments were approved by the University of California, Irvine
Institutional Animal Care and Use Committee.
Antibody production and administration
Rabbit polyclonal antiserum was generated to a 17-amino acid
portion of the amino-terminus ligand binding domain of CXCR2
(MGEFKVDKFNIEDFFSG) [75]. In our hands, the CXCR2
antiserum specifically blocks CXCR2 dependent infiltration of
neutrophils into the peritoneum of mice following thioglycollate
irritation [76] and does not bind rabbit complement and deplete
neutrophils in vitro. For in vivo neutralization during JHMV
infection, 0.5 ml of anti-CXCR2 or control normal rabbit serum
(NRS) was administered intraperitoneally (i.p.) on days 21, 1, 3, 5,
7, 9, and 11 p.i. or days 2, 4, 6, 8, and 10 p.i.
Semi-quantitative real-time PCR
Total cDNA from the brains of sham and JHMV infected mice
at days 1, 3, 7, 12, 15, 18, and 21 p.i. was generated as previously
described [77]. Real-time Taqman analysis for HPRT, CXCR2,
CXCL1, CXCL2, and CXCL5 was performed using a BioRad
(Hercules, Ca) iCycler with previously described primers and
probes [78,79]. CXCR2 and CXCL1, 22, and 25 expression was
normalized to HPRT. Probes were purchased from Integrated
DNA Technologies (Coralville, IA), and primers were purchased
from Invitrogen (Carlsbad, CA). iQ Supermix (BioRad) was used
for all reactions. Assay conditions were as follows: a 4.5 min initial
denaturation at 95uC, and 45 cycles of 30 sec at 95uC and 1 min
at 58uC. Data were analyzed with BioRad iCycler iQ5 and
quantified with the Relative Expression Software Tool [80].
Flow cytometric analysis
Flow cytometry was performed as previously described
[12,17,36]. Isolated cells were Fc blocked with anti-CD16/32
1:200 (BD Biosciences, CA) and immunophenotyed with fluores-
cent antibodies (BD Biosciences) specific for the following cell
surface markers: CD4 (L3T4), CD8b (53–5.8), CD8a (53–6.7),
CD11b (M1/70), Ly6G (1A8), Ly6G/C (RB6–8C5), CD44 (IM7),
CD25 (7D4), CD127 (A7R34, E Biosciences, Ca), CD45 (30-F11,
E Biosciences), and F4/80 (CI:A3-1, Ab Direct, NC. Appropriate
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of viral specificity, isolated CNS cells, splenocytes, or cervical
lymph node cells (CLN, isolated at day 7 p.i.) were either stained
with H-2
b-S510 tetramer (Beckman Coulter, CA) or stimulated ex
vivo for 6 h with 5 mM of the immunodominant CD4 epitope
M133–147 [38], immunodominant CD8 epitope S510–518 [39], or
the subdominant CD8 epitope S598–605 [37] and GolgiStop
(Cytofix/Cytoperm kit, BD Biosciences), and the production of
IFNc was determined by intracellular staining. Cells were Fc
blocked with CD16/32 and stained with FITC or APC conjugated
CD4, CD8a, or CD8b antibodies (BD Biosciences) before being
fixed and permeablized with the Cytofix/Cytoperm kit and
stained with PE conjugated IFNc (XMG1.2, BD Biosciences).
Appropriate isotype antibodies were used for each antibody. For
CXCR2 staining isolated Fc – blocked cells were stained rabbit
CXCR2 anti-serum (1:1000) for 1 hour. NRS at 1:1000 was used
as a serum control. Cells were then washed and stained with
APC – conjugated donkey anti-rabbit antibodies (1:200, Jackson
Immuno) for 30 min. Cells were run on a FACStar flow cytometer
(BD Biosciences) and analyzed with FlowJo software (TreeStar,
OR).
Histology
Brains and spinal cords from 4% paraformaldehyde perfused
mice were removed and fixed overnight in 4% paraformaldehyde
at 4uC. Tissues were embedded in paraffin and stained with
hematoxylin and eosin to determine the extent of inflammation.
Immunostaining
Brains and spinal cords from 4% paraformaldehyde perfused
mice were removed and fixed overnight in 4% paraformaldehyde
at 4uC and cryoprotected in 20% sucrose. Tissue sections (7 mm)
were fixed in 4% paraformaldehyde and blocked in 10% normal
donkey serum, 0.3% Triton X 100. Immunostaining for CXCL1
and GFAP was performed serially using polyclonal goat anti-
CXCL1 (2 ug/ml, R&D Systems, MN) and polyclonal chicken
anti-GFAP (1:500 Abcam, MA) overnight at 4uC. Cy-2 or Dylight
549 conjugated donkey secondary antibodies (1:200, Jackson
ImmunoResearch, PA) were used for visualization. Hoechst 33342
(Invitrogen) was used to stain nuclei prior to mounting coverslips.
Evans Blue extravasation
At day 3 p.i., mice were injected with 200 mlo f2 %( w / v )E v a n ’ s
Blue in sterile PBS intraorbitally. Two hours later, brains and
kidneys from PBS perfused mice were removed and homogenized
in formamide (20 ml/g wet weight). Homogenates were incubated
overnight, clarified by centrifugation, and assayed at 620 and
720 nm. CNS tissue turbidity was calculated [2log(OD620) =0.964
(2log(OD740) 20.0357] and subtracted from the original A(620)
[25,81]. Relative permeability was calculated as the ratio of Evans
blue extravasation (mg/ml per gram of tissue) of brain to kidney
homogenates.
MMP activity
Brains from PBS perfused mice were homogenized in 50 mM
Tris-HCL 0.5% TritonX-100 pH 7.6 and clarified by centrifuga-
tion. 15 mg of homogenate were separated on polyacrylamide gels
containing 1% gelatin (BioRad) in the absence of reducing agents.
Gels were washed for 20 minutes and incubated in developing
buffer (BioRad) for 2 days at 37uC. Gels were stained with
Coomassie R-250 and destained in 10% acetic acid and 10%
methanol. Quantification was performed with Image J software (v
1.42l, NIH) and expressed relative to sham activity.
Neutrophil isolation and chemotaxis
Neutrophils were enriched from bone marrow as previously
described [82]. Femurs and tibias were dissected from CXCR2+/+
or CXCR22/2 mice. Marrow was flushed, and red blood cells
lysed. Neutrophils were enriched using a 5 step percoll cushion:
45%, 50%, 55%, 62%, and 81%. Cells were collected from
between the 81% and 62% percoll layers. Cells were washed,
warmed at 37uC for 10 min, and 10
6 cells were plated into the top
well of a prewarmed 6.5 mm 5 mm transwell plate (Corning, NY
#93421). Chemokine dilutions (Peprotech) at the indicated
concentrations were made in the bottom well. Plates were
incubated for 3 hours before cells in the bottom well were
collected and counted. Data is presented as % input.
CXCR1 PCR
Neutrophils wereenriched fromthebonemarrowsof CXCR2+/+
and CXCR22/2 mice and cDNA was generated as previously
described[77].PCRwasperformedupon thegeneratedcDNAwith
primers specific for CXCR1: forward 59-GGGTGAAGCCAC-
AACAGATT, reverse 59-CGGTGTGTCAAAACCTCCTT and
rpL32: forward 59-AAGCGAAACTGGCGGAAACC, reverse
59-CGTAGCCTGGCGTTGGGATT. Reaction conditions for
CXCR1 were as follows: step 1, initial denaturation at 94uC for
3 min; step 2, denaturation at 94uC for 30 s; step 3, annealing at
58uC for 1 min; step 4, extension at 72uC for 30 s. Steps 2–4 were
repeated 39 times for a total of 40 cycles. Reaction conditions for
rpL32 were the same as above, except the annealing step was
performed at 53uC. Sequencing of PCR amplicons confirmed
primer specificity.
Statistical analysis
All data is presented as average 6 SEM. Statistically significant
differences between groups of mice treated with anti-CXCR2 or
NRS were assessed by one way ANOVA. Statistically significant
differences between CXCR22/2 and CXCR2+/+ mice were
assessed by a two-tailed Mann Whitney U Test. Statistical
significance on survival was performed with a Fisher Exact test.
P values less than 0.05 were considered significant.
Supporting Information
Figure S1 CXCR2 neutralization reduces levels of circulating
blood neutrophils. C57BL/6 mice were infected i.c. with 500 pfu
JHMV, administered CXCR2 antiserum or control normal rabbit
serum (NRS) days -1 and +1 p.i. and sacrificed at day 3 p.i. to
assess neutrophil levels within the blood. Blood was removed via
the right ventricle of the heart and diluted into 1% BSA 5 mM
EDTA in 1x PBS. Red blood cells were removed and the
remaining cells were processed for FACS analysis with Ly6G/C
(RB6-8C5) and CD11b specific antibodies. (A) Representative dot
blots from experimental mice determining the frequency of
neutrophils (Ly6G/C
high/CD11b
+) in blood. The frequency
(average{plus minus}SEM) of gated cells is indicated. (B) CXCR2
antiserum treatment significantly reduced (p,0.05) but did not
eliminate circulating neutrophils within the blood. Data in panels
(A and B) are representative of two independent experiments with
a minimum of 4 mice per group. The sham group did not receive
any serum injections.
Found at: doi:10.1371/journal.ppat.1000648.s001 (0.54 MB PDF)
Figure S2 CXCR2 neutralization following JHMV infection
does not affect mortality, viral burden, or T cell accumulation.
C57BL/6 mice were infected i.c. with 500 PFU JHMV,
administered CXCR2 antiserum or control normal rabbit serum
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indicated days p.i. to assess viral burden and T cell infiltration
within the brain. This treatment schedule did not alter (A)
mortality (anti-CXCR2, n=19; NRS, n=23) or (B) the ability to
control viral replication measured at day 12 p.i. (anti-CXCR2,
n=4–10; NRS, n=4–8). Moreover, CD4+ (C) and CD8b+ (D) T
cell accumulation within the brain was unaffected. (E) The
accumulation of neutrophils between days 2 and 3 was however
significantly reduced (p,0.01) following CXCR2 neutralization
compared to control mice. Data in panels (C, D, & E) are
representative of two independent experiments with a minimum of
4 mice per treatment group.
Found at: doi:10.1371/journal.ppat.1000648.s002 (0.87 MB PDF)
Figure S3 CXCR2 deficient mice generate JMHV - specific T
cells. CXCR22/2 mice (n=2) and CXCR2+/+ (n=4) littermates
controls were infected i.p. with 2.5610
5 PFU JHMV. Isolated
splenocytes were collected 7 days later and or stimulated ex vivo for
6 hours with 5 mM of the immunodominant CD8 epitope S510–518
or the immunodominant CD4 epitope M133–147 and stained for
IFN-c production (A) or stained with S510–518 MHC-I tetramer
(B).
Found at: doi:10.1371/journal.ppat.1000648.s003 (0.57 MB PDF)
Figure S4 CXCR2 antiserum does not alter neutrophil
infiltration in CXCR2 - deficient mice. CXCR2+/+ and
CXCR22/2 mice were infected i.c. with 500 pfu JHMV, treated
with either 0.5 ml of anti-CXCR2 or control antisera on days -1
and +1 p.i., and sacrificed at day 3 p.i. to assess neutrophil
infiltration into the brain. (A) CXCR2 antiserum did not affect
neutrophil infiltration into the brains of CXCR22/2 mice, while
(B) anti-CXCR2 completely prevented the infiltration of neutro-
phils into the brains of CXCR2+/+ mice. Representative FACS
plots are shown with the average frequencies 6 SEM, n=3–4 for
each treatment group.
Found at: doi:10.1371/journal.ppat.1000648.s004 (0.64 MB PDF)
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